Medtronic (MDT) Equity Average (2014 - 2026)

Medtronic has disclosed Equity Average across 13 years of filings, most recently posting $49.0 billion for Q1 2026.

• Equity Average for Q1 2026 came in at $49.0 billion, changed 0.28% year-over-year; the trailing twelve-month figure through Jan 2026 was $49.0 billion (changed 0.28% YoY), and the FY2025 annual result was $49.3 billion, down 3.34% from the prior year.
• Equity Average came in at $49.0 billion for Q1 2026 at Medtronic, up from $48.5 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $52.8 billion in Q3 2022 to a low of $48.2 billion in Q3 2025.
• The 5-year median for Equity Average is $51.5 billion (2023), against an average of $50.7 billion.
• Across the five-year window, Equity Average advanced 3.58% in 2022 and decreased 5.96% in 2024, its largest moves.
• Medtronic's Equity Average stood at $52.4 billion in 2022, then fell by 1.8% to $51.5 billion in 2023, then fell by 5.96% to $48.4 billion in 2024, then climbed by 0.12% to $48.5 billion in 2025, then gained by 1.1% to $49.0 billion in 2026.
• The last three Equity Average figures came in at $49.0 billion (Q1 2026), $48.5 billion (Q4 2025), and $48.2 billion (Q3 2025), per Business Quant data.